1. Home
  2. AXTA vs KRYS Comparison

AXTA vs KRYS Comparison

Compare AXTA & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axalta Coating Systems Ltd.

AXTA

Axalta Coating Systems Ltd.

HOLD

Current Price

$30.21

Market Cap

6.2B

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$216.45

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXTA
KRYS
Founded
1910
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Paints/Coatings
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.3B
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
AXTA
KRYS
Price
$30.21
$216.45
Analyst Decision
Buy
Strong Buy
Analyst Count
14
9
Target Price
$37.00
$214.22
AVG Volume (30 Days)
4.7M
325.5K
Earning Date
10-28-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
40.67
275.72
EPS
2.09
6.66
Revenue
$5,166,000,000.00
$373,164,000.00
Revenue This Year
N/A
$34.33
Revenue Next Year
$2.24
$48.04
P/E Ratio
$14.40
$32.72
Revenue Growth
N/A
54.51
52 Week Low
$26.28
$122.80
52 Week High
$40.80
$221.84

Technical Indicators

Market Signals
Indicator
AXTA
KRYS
Relative Strength Index (RSI) 60.31 70.43
Support Level $29.30 $213.24
Resistance Level $30.57 $221.84
Average True Range (ATR) 0.88 6.84
MACD 0.16 0.66
Stochastic Oscillator 86.33 78.79

Price Performance

Historical Comparison
AXTA
KRYS

About AXTA Axalta Coating Systems Ltd.

Axalta Coating Systems Ltd is a manufacturer, marketer and distributor of high-performance coatings systems. It operates in two segments, The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial. The Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The company operates in the geographic areas of North America, EMEA countries, Asia-Pacific, and Latin America.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: